Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Completed · Phase 2

Conditions studied: Intracerebral Hemorrhage

In brief

This study will determine if NXY-059 is safe in patients with an acute stroke caused by bleeding in the central nervous system. The primary objective was to assess the safety and tolerability of NXY-059 compared to placebo.

Key facts

Study ID

NCT00075959

Run by

AstraZeneca

People needed

600

Starts

2004-08-01

Expected to finish

2006-01-01

Last updated by the study team

2013-01-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females
• Intracerebral Hemorrhage as the cause of stroke symptoms
• Onset of symptoms within 6 hours
• Full functional independence prior to the present stroke

You may not qualify if…

• Unconsciousness
• Subjects who are unlikely to complete the infusion of investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.
• Severe illness with life expectancy less than 6 months.
• Known severe kidney disorder.
• Current known alcohol or illicit drug abuse or dependence.
• Pregnant or breast-feeding.
• Treatment with acetazolamide and methotrexate is not permitted during the infusion
• Participation in a previous clinical study within 7 days.
• Meets all other exclusion criteria

Where it is running

• Research Site — Scottsdale, Arizona, United States
• Research Site — Fort Smith, Arkansas, United States
• Research Site — Carmichael, California, United States
• Research Site — Sacramento, California, United States
• Research Site — San Diego, California, United States
• Research Site — San Jose, California, United States
• Research Site — Santa Rosa, California, United States
• Research Site — Walnut Creek, California, United States
• Research Site — Danbury, Connecticut, United States
• Research Site — Melbourne, Florida, United States
• Research Site — Ocala, Florida, United States
• Research Site — Pompano Beach, Florida, United States
• Research Site — Port Charlotte, Florida, United States
• Research Site — Punta Gorda, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Weston, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Decatur, Georgia, United States
• Research Site — Duluth, Georgia, United States
• Research Site — Lawrenceville, Georgia, United States
• Research Site — Honolulu, Hawaii, United States
• Research Site — Arlington Heights, Illinois, United States
• Research Site — Maywood, Illinois, United States
• Research Site — Fort Wayne, Indiana, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.